A detailed history of Summit Partners Public Asset Management, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Summit Partners Public Asset Management, LLC holds 622,498 shares of NTRA stock, worth $66.3 Million. This represents 2.02% of its overall portfolio holdings.

Number of Shares
622,498
Holding current value
$66.3 Million
% of portfolio
2.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$59.21 - $92.9 $36.9 Million - $57.8 Million
622,498 New
622,498 $56.9 Million
Q4 2021

Feb 14, 2022

SELL
$86.26 - $119.0 $295,785 - $408,051
-3,429 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$100.17 - $126.36 $343,482 - $433,288
3,429 New
3,429 $382,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $10.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Summit Partners Public Asset Management, LLC Portfolio

Follow Summit Partners Public Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.